Skip to main content
. 2016 Jan 25;12(1):e1005395. doi: 10.1371/journal.ppat.1005395

Fig 4. Classification of primary CMV infection with moderately symptomatic neonates.

Fig 4

(A) The amniotic fluid peptide content of CMV-infected fetuses with moderate neonatal symptoms (hearing loss (HL) or hearing loss and vestibular dysfunction (HL+VD)) was scored with the CMV34 classifier. The scores allowed a nearly significant difference after analysis by Mann-Whitney test for independent samples (p = 0.06). CMV DNA levels in amniotic fluid and fetal blood (B and C, respectively) and the fetal platelet count (D) were clearly not different between hearing loss versus hearing loss and vestibular dysfunction (p values of 0.32, 0.19 and 0.73, respectively, Mann-Whitney test for independent samples).